These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17084902)

  • 21. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL
    Clin Microbiol Infect; 2005 Jun; 11(6):486-92. PubMed ID: 15882199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility to fluconazole of Candida clinical isolates determined by FUN-1 staining with flow cytometry and epifluorescence microscopy.
    Pina-Vaz C; Sansonetty F; Rodrigues AG; Costa-DE-Oliveira S; Martinez-DE-Oliveira J; Fonseca AF
    J Med Microbiol; 2001 Apr; 50(4):375-382. PubMed ID: 11289523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methods for the determination of the sensitivity of Candida strains to fluconazole: focus of a micromethod and correlation with 2 other techniques].
    Goutaland C; Piens MA
    Pathol Biol (Paris); 1996 Oct; 44(8):724-8. PubMed ID: 8977933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes.
    Castro C; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
    Chemotherapy; 2008; 54(6):427-30. PubMed ID: 18824849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
    Traboulsi RS; Mukherjee PK; Ghannoum MA
    Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR; Darwish RM
    Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antifungal susceptibility using flow cytometry.
    Pina-Vaz C; Rodrigues AG
    Methods Mol Biol; 2010; 638():281-9. PubMed ID: 20238277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.
    Asadzadeh M; Al-Sweih NA; Ahmad S; Khan ZU
    Mycoses; 2008 Jul; 51(4):318-23. PubMed ID: 18855844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardization of antifungal susceptibility variables for a semiautomated methodology.
    Rodríguez-Tudela JL; Cuenca-Estrella M; Díaz-Guerra TM; Mellado E
    J Clin Microbiol; 2001 Jul; 39(7):2513-7. PubMed ID: 11427562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of antifungal susceptibility testing methods.
    Arikan S
    Med Mycol; 2007 Nov; 45(7):569-87. PubMed ID: 17885947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorhexidine is a highly effective topical broad-spectrum agent against Candida spp.
    Salim N; Moore C; Silikas N; Satterthwaite J; Rautemaa R
    Int J Antimicrob Agents; 2013 Jan; 41(1):65-9. PubMed ID: 23084595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.